Literature DB >> 8817692

Developmental regulation of circulating insulin-like growth factor-binding proteins in normal pregnancies and in pre-eclampsia.

M S Lewitt1, F P Scott, N M Clarke, R C Baxter.   

Abstract

The insulin-like growth factors (IGFs) and their binding properties (IGFBPs) are believed to play important roles in the growth and development of the human fetus. They have been implicated in the pathophysiology of pre-eclampsia. In this study we have characterized the developmental regulation, in normal and pre-eclamptic pregnancies, of IGFs and IGFBPs in maternal serum, neonatal serum and amniotic fluid. In neonatal cord serum IGFBP-1, -2 and -6 decreased with increasing gestational age. In contrast, the ternary complex and its components, IGF-I, IGFBP-3 and ALS increased with gestation. We show that while ALS is an important limiting factor for ternary complex formation in the fetal circulation, there is a fraction of IGFBP-3 which is unable to form this complex. IGFs and IGFBPs in the maternal and fetal circulation were similar in normal and pre-eclamptic pregnancies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8817692     DOI: 10.1016/0955-2235(95)00030-5

Source DB:  PubMed          Journal:  Prog Growth Factor Res        ISSN: 0955-2235


  4 in total

1.  Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis.

Authors:  Jisook Park; Dong Hyun Cha; Soo Jae Lee; Young Nam Kim; Young Hwan Kim; Kwang Pyo Kim
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

2.  Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety.

Authors:  David Ley; Ingrid Hansen-Pupp; Aimon Niklasson; Magnus Domellöf; Lena E Friberg; Jan Borg; Chatarina Löfqvist; Gunnel Hellgren; Lois E H Smith; Anna-Lena Hård; Ann Hellström
Journal:  Pediatr Res       Date:  2012-10-24       Impact factor: 3.756

3.  Heterogeneity of the growth phenotype and birth size in acid-labile subunit (ALS) deficiency.

Authors:  H L Storr; R Prasad; I K Temple; L A Metherell; M O Savage; J M Walker
Journal:  J Endocrinol Invest       Date:  2014-10-29       Impact factor: 4.256

Review 4.  IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

Authors:  Ann Hellstrom; David Ley; Boubou Hallberg; Chatarina Lofqvist; Ingrid Hansen-Pupp; Luca A Ramenghi; Jan Borg; Lois E H Smith; Anna-Lena Hard
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.